Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ARR NASDAQ:BBH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARRARMOUR Residential REIT$15.20+3.1%$16.26$13.18▼$21.08$1.39B1.384.93 million shs4.04 million shsBBHVanEck Biotech ETF$166.98+0.1%$159.22$135.34▼$183.64$351.88M0.735,877 shs4,501 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARRARMOUR Residential REIT0.00%+0.90%-8.85%-4.88%-25.20%BBHVanEck Biotech ETF0.00%+0.08%+1.12%+14.11%-8.62%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARRARMOUR Residential REIT3.271 of 5 stars1.14.02.50.03.50.81.9BBHVanEck Biotech ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARRARMOUR Residential REIT 2.17Hold$16.005.30% UpsideBBHVanEck Biotech ETF 2.66Moderate Buy$166.98N/ACurrent Analyst Ratings BreakdownLatest MIGO, JAGI, ARR, and BBH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/10/2025ARRARMOUR Residential REITUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$14.00 ➝ $16.00(Data available from 8/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARRARMOUR Residential REIT-$21.36M-65.15$3.64 per share4.17$18.12 per share0.84BBHVanEck Biotech ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARRARMOUR Residential REIT-$14.39M-$0.24N/A3.58N/A-4.55%15.89%1.64%10/22/2025 (Estimated)BBHVanEck Biotech ETFN/AN/A0.00∞N/AN/AN/AN/AN/ALatest MIGO, JAGI, ARR, and BBH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/23/2025Q2 2025ARRARMOUR Residential REIT$0.81$0.77-$0.04-$0.94$52.77 million$84.19 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARRARMOUR Residential REIT$2.8818.95%N/AN/A N/ABBHVanEck Biotech ETF$1.250.75%N/AN/AN/ALatest MIGO, JAGI, ARR, and BBH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/22/2025ARRARMOUR Residential REITaug 25$0.2417.2%8/15/20258/15/20258/29/20256/25/2025ARRARMOUR Residential REITmonthly$0.2417.4%7/15/20257/15/20257/30/20255/30/2025ARRARMOUR Residential REITmonthly$0.2417.7%6/16/20256/16/20256/27/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARRARMOUR Residential REITN/A0.040.04BBHVanEck Biotech ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARRARMOUR Residential REIT54.17%BBHVanEck Biotech ETF32.05%Insider OwnershipCompanyInsider OwnershipARRARMOUR Residential REIT0.35%BBHVanEck Biotech ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARRARMOUR Residential REITN/A91.59 million91.27 millionOptionableBBHVanEck Biotech ETFN/A2.11 millionN/AOptionableMIGO, JAGI, ARR, and BBH HeadlinesRecent News About These CompaniesVanEck Biotech ETF (NASDAQ:BBH) Short Interest Down 37.5% in JulyAugust 19, 2025 | americanbankingnews.comBBH: A Biotech Fund That's Ripe For A Major TurnaroundAugust 8, 2025 | talkmarkets.comBBH- A Biotech Fund That's Ripe for a Major TurnaroundAugust 5, 2025 | finance.yahoo.comShould You Invest in the VanEck Biotech ETF (BBH)?June 30, 2025 | zacks.comVanEck Biotech ETF Dividends | NASDAQ:BBH | BenzingaMay 29, 2025 | benzinga.comBBH: Fear Of Price Controls Is Not The ProblemMay 14, 2025 | seekingalpha.comShould You Invest in the VanEck Biotech ETF (BBH)?April 29, 2025 | zacks.comShould You Invest in the VanEck Biotech ETF (BBH)?February 25, 2025 | zacks.comAre Wall Street Analysts Predicting Vertex Pharmaceuticals Stock Will Climb or Sink?February 20, 2025 | msn.comVanEck Biotech ETF declares annual distribution of $1.2517December 27, 2024 | msn.comShould You Invest in the VanEck Biotech ETF (BBH)?December 24, 2024 | zacks.comWhen (BBH) Moves Investors should ListenNovember 20, 2024 | news.stocktradersdaily.comNTraining The Immune System To Attack Cancer With ProbioticsOctober 26, 2024 | securities.ioSShould You Invest in the VanEck Biotech ETF (BBH)?October 22, 2024 | zacks.comFighting Cancer with BioTech – Why mRNA Vaccines Are Such a Leap ForwardOctober 18, 2024 | securities.ioSLearn to Evaluate (BBH) using the ChartsOctober 8, 2024 | news.stocktradersdaily.comNAre Rate Cuts Bad News For BIZD ETF?September 10, 2024 | seekingalpha.comEmphasize Consistency To Navigate VolatilitySeptember 7, 2024 | seekingalpha.com(BBH) Investment Analysis and AdviceSeptember 2, 2024 | news.stocktradersdaily.comNVanEck Fabless Semiconductor ETF (NASDAQ:SMHX) Quotes, Forecast and News SummaryAugust 29, 2024 | benzinga.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 2025Trump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli LillyBy Jordan Chussler | August 9, 2025How 2 Deals in 48 Hours Changed Everything for Joby AviationBy Jeffrey Neal Johnson | August 4, 2025Next-Gen Defense: 3 Stocks Riding the New Global Arms RaceBy Nathan Reiff | August 18, 20253 Surprising Earnings Winners Changing Their Market NarrativeBy Dan Schmidt | August 4, 2025MIGO, JAGI, ARR, and BBH Company DescriptionsARMOUR Residential REIT NYSE:ARR$15.20 +0.46 (+3.09%) Closing price 08/22/2025 03:59 PM EasternExtended Trading$15.19 -0.01 (-0.06%) As of 08/22/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ARMOUR Residential REIT, Inc. invests in residential mortgage-backed securities (MBS) in the United States. Its securities portfolio primarily consists of the United States Government-sponsored entity's (GSE) and the Government National Mortgage Administration's issued or guaranteed securities backed by fixed rate, hybrid adjustable rate, and adjustable-rate home loans; and unsecured notes and bonds issued by the GSE and the United States treasuries, as well as money market instruments. The company has elected to be taxed as a real estate investment trust. As a result, it would not be subject to corporate income tax on that portion of its net income that is distributed to shareholders. ARMOUR Residential REIT, Inc. was incorporated in 2008 and is based in Vero Beach, Florida.VanEck Biotech ETF NASDAQ:BBH$166.98 +0.25 (+0.15%) Closing price 08/22/2025 03:58 PM EasternExtended Trading$167.06 +0.08 (+0.05%) As of 08/22/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Workday: Institutions Are Buying This Stock, Shouldn’t You? Alphabet’s Breakout Potential: From Laggard to AI Leader After Earnings Miss, Walmart Is Still a Top Consumer Staples Play Should You Join Buffett and Invest in Constellation Brands? Can Identity Security Fuel CrowdStrike’s Next Growth Phase? 3 Robotics Stocks at the Heart of the Robotics Revolution Analog Devices and an AI-Driven Semiconductor Supercycle Shopify’s Risk-Reward Profile Is Suddenly Red Hot Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access